Call Us: +8618502081859Email: Derek@gzcypack-china.com
enLanguage

COVID-19 Latest News

May 26, 2020

On the 24th local time, U.S. President ’s Assistant to National Security Affairs, O'Brien, was interviewed by the US media and once again discredited that China is "stealing" US vaccine-related research results. On the evening of the 25th, Chinese Ministry of Foreign Affairs spokesperson Hua Chunying mentioned Obryan ’s reports on Twitter. She pointed out the strange logic of the so-called “stealing” and reminded that “China has a history of 5000 years, while Only less than 250 years old. "



hua chunying

In the tweet, Hua Chunying wrote: "It's really interesting to hear some American officials talk about vaccines. If someone has something better than me, then he must have stolen from me. Is this normal logic? ? Remember, China has 5,000 years of history, while the United States has less than 250 years of history. "


In response to O'Brien's discredited remarks, spokesman Zhao Lijian also responded at the Foreign Ministry's regular press conference on the 25th. He emphasized that the US side's claims are groundless. In fact, China has made significant progress in developing new coronavirus vaccines. China supports countries to strengthen information sharing on the new coronary pneumonia epidemic situation, exchange beneficial experiences and practices in prevention and control, and develop international cooperation in vaccine and drug research and development.


At 21:00 on the evening of May 22, the international academic journal "The Lancet" published the results of the first phase I clinical trial of the world's first recombinant adenovirus type 5 vector new crown vaccine. Wei. At the same time, Richard Houghton, editor-in-chief of The Lancet, shared the news through social media and praised: The first human test results of this new coronavirus vaccine found that it has good safety and tolerance, and Can induce a rapid immune response. "These results represent an important milestone."


Further reading:


Over 5.47 million cases of new coronary pneumonia have been diagnosed globally, and 1.66 million cases in the United States


According to statistics from Johns Hopkins University in the United States, as of 6:32 on May 26, the cumulative number of confirmed cases of global new coronary pneumonia reached 5471768 cases and 344911 deaths.


Among them, 1660072 cases were diagnosed in the United States and 98184 cases died, ranking first in the world in the number of diagnoses and deaths. 29229 cases of deaths in New York, is still the hardest hit by the new crown epidemic in the United States.


The other two countries with cumulative diagnosed cases exceeding 300,000 are Brazil (363,211 cases) and Russia (353,427 cases).


China steals vaccine achievements, is the United States the world's number one?


At the press conference, a reporter asked: O'Brien also said on Sunday that the United States will be the first country in the world to be able to produce a new coronavirus vaccine. Austria also said that China is "stealing" relevant US research. What's your opinion?


In response, Zhao Lijian replied that the US side's claims are groundless. In fact, China has made significant progress in developing new coronavirus vaccines. China supports countries to strengthen information sharing on the new coronary pneumonia epidemic situation, exchange beneficial experiences and practices in prevention and control, and develop international cooperation in vaccine and drug research and development.


He emphasized that the research and development of the new coronavirus vaccine is not a battle between China and the United States, but a battle between humans and viruses. Which country is the first to complete the vaccine research and development and put into use is a positive contribution to the fight against the epidemic in humans. Human beings are racing against the virus, and every day a fresh life is ruthlessly taken away by the virus. Vaccines are the key to defeating the virus. "We look forward to more success stories in the field of vaccine research and development. We also look forward to continuing to work with the international community to contribute to the promotion of vaccine research and other global anti-epidemic cooperation and jointly build a human health and health community."